CHNA Loncar China BioPharma ETF
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
No price history on file.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| CHNA | — | — | — | — | — | — |
| Equity average (4748 funds) | -5.3% | -6.8% | +27090.2% | +22162.3% | +27.3% | +2.9% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$1K net.
Holdings · as of Apr 17, 2023
| # | Holding | Weight |
|---|---|---|
| 1 | 9939 | 4.42% |
| 2 | 1548 | 3.88% |
| 3 | 2196 | 3.25% |
| 4 | 1093 | 3.00% |
| 5 | 6185 | 2.57% |
| 6 | 867 | 2.39% |
| 7 | 3759 | 2.36% |
| 8 | 9966 | 2.26% |
| 9 | 2096 | 2.25% |
| 10 | 460 | 2.24% |
| 11 | 1177 | 2.24% |
| 12 | 2269 | 2.15% |
| 13 | 9969 | 2.12% |
| 14 | LEGN Legend Biotech Corporation | 2.06% |
| 15 | 2359 | 2.01% |
| 16 | ZLAB Zai Lab Limited | 1.99% |
| 17 | 1873 | 1.92% |
| 18 | 1530 | 1.89% |
| 19 | BGNE BeiGene, Ltd. | 1.89% |
| 20 | 1513 | 1.87% |
| 21 | 1801 | 1.87% |
| 22 | 1099 | 1.85% |
| 23 | 2607 | 1.83% |
| 24 | 2616 | 1.82% |
| 25 | 6826 | 1.80% |
| 26 | 3347 | 1.78% |
| 27 | 3320 | 1.77% |
| 28 | 1477 | 1.74% |
| 29 | 1877 | 1.74% |
| 30 | 6978 | 1.72% |
| 31 | 2005 | 1.69% |
| 32 | 512 | 1.68% |
| 33 | IMAB I-Mab | 1.65% |
| 34 | 874 | 1.63% |
| 35 | 3692 | 1.58% |
| 36 | 9995 | 1.57% |
| 37 | 9926 | 1.52% |
| 38 | 775 | 1.47% |
| 39 | 2696 | 1.42% |
| 40 | 6855 | 1.34% |
| 41 | 1167 | 1.31% |
| 42 | 9989 | 1.30% |
| 43 | 6996 | 1.30% |
| 44 | BNR Burning Rock Biotech Limited | 1.29% |
| 45 | HCM HUTCHMED (China) Limited | 1.29% |
| 46 | 2186 | 1.24% |
| 47 | 1558 | 1.23% |
| 48 | 6998 | 1.22% |
| 49 | 1952 | 1.14% |
| 50 | 2142 | 1.14% |
| 51 | GTH Genetron Holdings Limited | 1.06% |
| 52 | 2126 | 0.97% |
| 53 | 950 | 0.92% |
| 54 | 2552 | 0.88% |
| 55 | GRCL Gracell Biotechnologies Inc. | 0.77% |
| 56 | CASI CASI Pharmaceuticals, Inc. | 0.50% |
| 57 | CASH&OTHER | 0.22% |
Sector breakdown
Not on file.
Country breakdown
Not on file.
Distributions
| Date | Per unit |
|---|---|
| Oct 16, 2023 | $0.0487 |
| Dec 29, 2021 | $3.0314 |
| Dec 30, 2020 | $0.1546 |
| Dec 23, 2019 | $0.0402 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in CHNA in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 21, 2026. This is historical data, not investment advice. Report a data error
